logo

For the Inventor, By the Inventor

London, United Kingdom

Israel Simon Gloger

This inventor holds 7 USPTO granted patents. Top assignees: Smithkline Beecham Corporation, Smithkline Beechman Corporation. Active years: 1999-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Israel Simon Gloger. Retrieved from https://idiyas.com/inventor/israel-simon-gloger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 7

% Patents Active = 57.1

Average Co-Inventor Count = 5.4

ph-index = 3

Forward Citations = 25(Granted Patents)


Location History:

  • East Finchley, GB (1999 - 2001)
  • London, GB (2001 - 2008)

Company Filing History:

goldMedal6 out of 2,198 
 
Smithkline Beecham Corporation
 patents
silverMedal1 out of 7 
 
Smithkline Beechman Corporation
 patents

Years Active: 1999-2008

Loading Chart...
7 patents (USPTO):Explore Patents
1. 7314742 - Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy (2008-01-01),
2. 7045329 - Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy (2006-05-16),
3. 6426405 - Neurotransmitter transporter SC6 (2002-07-30),
4. 6238883 - Neurotransmitter transporter SC6 (2001-05-29),
5. 6187908 - Tubby 2 polypeptides (2001-02-13),
6. 6177257 - Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy (2001-01-23),
7. 5968818 - Lipoprotein associated phospholipase A2, inhibitors thereof and use of (1999-10-19),

Title: The Innovative Journey of Israel Simon Gloger

Introduction: Israel Simon Gloger, an accomplished inventor based in London, GB, has made significant contributions to the field of biochemistry with a focus on lipoprotein-associated enzymes. With a portfolio of seven patents, Gloger's innovations are paving the way for advancements in diagnostics and therapeutic treatments.

Latest Patents: Among Gloger's most notable patents are those related to lipoprotein-associated phospholipase A2 (Lp-PLA2). His recent patents detail the enzyme Lp-PLA2 in its purified form and include an isolated nucleic acid molecule encoding this enzyme. Additionally, Gloger has developed methods involving inhibitors of Lp-PLA2 for therapeutic use, as well as screening compounds that identify potential Lp-PLA2 inhibitors. These innovations hold promise for improving diagnosis and therapy in related medical fields.

Career Highlights: Gloger has a commendable career trajectory, having worked with renowned organizations such as SmithKline Beecham Corporation. His contributions to the company and the broader biochemical community have been substantial, providing a foundation for further research and application.

Collaborations: Throughout his career, Gloger has collaborated with esteemed professionals, including colleagues Colin Houston MacPhee and David Graham Tew. These partnerships have undoubtedly enriched his work and facilitated the exploration of new ideas and innovations in his field.

Conclusion: Israel Simon Gloger stands as a testament to innovation in biochemistry, with a focus on lipoprotein-associated enzymes. His latest patents indicate a strong commitment to advancing medical science, showcasing how dedicated inventors contribute to diagnostics and therapy improvements. The path he has forged may inspire future inventors and researchers in their quest for groundbreaking discoveries.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…